Viewing StudyNCT00281658



Ignite Creation Date: 2024-05-05 @ 4:39 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00281658
Status: COMPLETED
Last Update Posted: 2023-02-10
First Post: 2006-01-23

Brief Title: Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-01-02
Start Date Type: ACTUAL
Primary Completion Date: 2010-06-18
Primary Completion Date Type: ACTUAL
Completion Date: 2021-11-23
Completion Date Type: ACTUAL
First Submit Date: 2006-01-23
First Submit QC Date: January 24 2006
Study First Post Date: 2006-01-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2011-06-01
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-02-09
Last Update Post Date: 2023-02-10
Last Update Post Date Type: ACTUAL